![]() Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. | MABION Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases. | ![]() Lion TCR Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases. | |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Konstantynów Łódzki, PL HQ | Locations Singapore, SG HQ Guangzhou, CN Singapore, SG Singapore, SG |
Employees | Employees 29723% increase | Employees 95 | Employees N/A |
Valuation ($) | Valuation ($) 1.1 b | Valuation ($) 21.7 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) €155.8m (FY, 2024) | Revenue (est.) zł69m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods zł19.2m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit €155.9m (FY, 2024) | Gross profit zł50.4m (FY, 2024) | Gross profit N/A |
Net income | Net income €15.2m (FY, 2024) | Net income (zł6.3m) (FY, 2024) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 267.3m | Total funding raised N/A | Total funding raised $ 20m |
Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases.
View companyLion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases.
View company